Lateral flow immunoassays are low cost, rapid and highly efficacious point-of-care devices, which have been used for SARS-CoV-2 antibody testing by professionals. However, there is a lack of ...
To the Editor — Commenting recently on rapid point-of-care tests, US COVID-19 coordinator Deborah Birx said, “We are very quality-oriented. We don’t want false positives.” 1 “If they are incredibly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results